ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.802,06
-0,19%
S&P 500
5.291,34
0,15%
US Dollar vs BRL
5,2861
0,68%
Bitcoin
70.272,01
2,13%
Brent Oil
77,45
-0,88%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Forte Biosciences Inc (FBRX)

  7. Forte Biosciences Inc (FBRX) Notícias

FBRX

Forte Biosciences (FBRX)

Forte Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:FBRX
DataHoraFonteTítuloCódigoCompanhia
13/05/202417:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBRXForte Biosciences Inc
13/05/202417:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBRXForte Biosciences Inc
16/02/202418:16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FBRXForte Biosciences Inc
14/02/202418:54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FBRXForte Biosciences Inc
05/01/202419:27Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:FBRXForte Biosciences Inc
03/01/202418:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
14/09/202317:00Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:FBRXForte Biosciences Inc
14/09/202311:50Business WireISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual MeetingNASDAQ:FBRXForte Biosciences Inc
11/09/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FBRXForte Biosciences Inc
08/09/202317:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FBRXForte Biosciences Inc
06/09/202316:15Business WireConcerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s BoardroomNASDAQ:FBRXForte Biosciences Inc
01/09/202318:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FBRXForte Biosciences Inc
29/08/202318:57Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FBRXForte Biosciences Inc
25/08/202311:10Edgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsNASDAQ:FBRXForte Biosciences Inc
25/08/202309:00Business WireConcerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to StockholdersNASDAQ:FBRXForte Biosciences Inc
24/08/202307:17Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:FBRXForte Biosciences Inc
23/08/202317:47Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:FBRXForte Biosciences Inc
17/08/202310:30Edgar (US Regulatory)Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwiseNASDAQ:FBRXForte Biosciences Inc
09/08/202313:23Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FBRXForte Biosciences Inc
02/08/202318:28Edgar (US Regulatory)Form PREC14A - Preliminary proxy statements, contested solicitationsNASDAQ:FBRXForte Biosciences Inc
26/06/202318:14Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:FBRXForte Biosciences Inc
26/06/202317:57Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FBRXForte Biosciences Inc
10/04/202309:06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FBRXForte Biosciences Inc
31/03/202317:37Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FBRXForte Biosciences Inc
31/03/202317:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FBRXForte Biosciences Inc
29/03/202312:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FBRXForte Biosciences Inc
23/03/202317:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FBRXForte Biosciences Inc
12/01/202318:04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FBRXForte Biosciences Inc
14/11/202218:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FBRXForte Biosciences Inc
17/08/202209:00Business WireCamac Partners Condemns Forte Biosciences’ Seemingly Defensive and Unjustifiable Capital RaiseNASDAQ:FBRXForte Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:FBRX

Seu Histórico Recente

EU
SMAJ
Departement Seine et Mar...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados